PGD in 47,XXY Klinefelter's syndrome patients

Size: px
Start display at page:

Download "PGD in 47,XXY Klinefelter's syndrome patients"

Transcription

1 Human Reproduction Update, Vol.9, No.4 pp. 319±330, 2003 DOI: /humupd/dmg029 PGD in 47,XXY Klinefelter's syndrome patients C.Staessen 1,3, H.Tournaye 1, E.Van Assche 2, A.Michiels 2, L.Van Landuyt 1, P.Devroey 1, I.Liebaers 2 and A.Van Steirteghem 1 1 Centre for Reproductive Medicine and 2 Centre for Medical Genetics, University Hospital, Dutch-speaking Free University of Brussels (Vrije Universiteit Brussel), Brussels, Belgium 3 To whom correspondence should be addressed at: Centre for Reproductive Medicine, Academisch Ziekenhuis, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 Brussels-Belgium. catherine.staessen@az.vub.ac.be The use of ICSI has been a major breakthrough in the treatment of male infertility. Even azoospermic patients with focal spermatogenesis in the testis, may bene t from the ICSI technique in order to father a child. As ICSI use has become more common, centres have introduced infertility treatment for Klinefelter patients. To date, 34 healthy children have been born using ICSI without PGD, and the conception of one 47,XXY fetus has been reported. In view of the possible risk of an increased gonosome number in the spermatozoa of Klinefelter patients, a safer approachðoffering these couples ICSI combined with PGDÐhas been used, and has resulted in the birth of three healthy children. Couples in which the male suffered from Klinefelter's syndrome were rst treated in 1995; these patients were offered ICSI + PGD using FISH technology, notably to enumerate the X and Y chromosomes. ICSI + PGD was performed in 32 cycles of 20 couples with spermatozoa originating from a fresh ejaculate (n = 1), testicular biopsy (n = 21) or frozen±thawed testicular biopsy (n = 10). Normal fertilization occurred in % of the successfully injected oocytes. On day 3 of development, 119 embryos from 29 cycles were of suf cient quality to undergo biopsy and subsequent PGD; a positive result was obtained in 113 embryos. Embryos were available for transfer in 26 cycles, with a mean of embryos per transfer. Eight pregnancies were obtained, and ve resulted in a delivery. A total of 113 embryos from couples with Klinefelter's syndrome was compared with 578 embryos from control couples with X-linked disease where PGD was used to determine gender. A signi cant fall occurred in the rate of normal embryos for couples with Klinefelter's syndrome (54.0%) compared with controls (77.2%). Moreover, a signi cantly increased risk of abnormalities was observed for sex chromosomes and autosomes; for each autosome separately, this reached signi cance level for chromosomes 18 and 21 only. Hence, a cautious approach is warranted in advising couples with non-mosaic Klinefelter's syndrome. Moreover, the use of ICSI + PGD or prenatal diagnosis should be carefully considered. Key words: FISH/ICSI/Klinefelter syndrome/pgd/testicular sperm Introduction In 1942, Klinefelter and colleagues rst described a syndrome characterized by gynaecomastia, aspermatogenesis, without aleydigism and increased excretion of FSH (Klinefelter et al., 1942), and some 17 years later this syndrome was related to a 47,XXY karyotype (Jacobs and Strong, 1959). Although most Klinefelter's syndrome patients are considered to have a non-mosaic 47,XXY karyotype, a mosaic 47,XXY/ 46,XY karyotype is found in about 10% of cases (Wilson and Grif n, 1987). Within the general population, the incidence of 47,XXY Klinefelter's syndrome is 0.1% (Nielsen and Wohlert, 1991), and this value reaches 3.1% in the infertile male population (Guichaoua et al., 1993). Although a few cases with proven paternity (Laron et al., 1982; Terzoli et al., 1992) have been reported, non-mosaic 47,XXY Klinefelter patients are in general considered to be sterile. The introduction of ICSI led to a change in the clinical approach towards fertility treatment in these patients. In cases with a 46,XY/47,XXY mosaic karyotype, spermatozoa can usually be recovered from the ejaculate, and fertilization has ensued after ICSI (Harari et al., 1995; Bielanska et al., 2000). Nonmosaic Klinefelter patients (47,XXY) are generally azoospermic owing to primary testicular failure, although in some cases focal spermatogenesis has been present and testicular spermatozoa have been recovered and successfully used for ICSI (Staessen et al., 1996; Tournaye et al., 1996). Investigations on the meiotic products of non-mosaic Klinefelter patients by direct analysis of the ejaculated or testicular spermatozoa with the uorescent in-situ hybridization (FISH) Human Reproduction Update 9(4) ã European Society of Human Reproduction and Embryology 2003; all rights reserved 319

2 C.Staessen et al. Table I. Overview of reported pregnancies obtained after ICSI treatment of patients with apparent non-mosaic Klinefelter's syndrome Reference PGDperformed No. of Outcome of pregnancy Karyotype (n) b cycles (n) a 47,XXY: ejaculated spermatozoa Hinney et al. (1997) No Case report Singleton: miscarriage at 9 weeks Abortion tissue: 46,XX CruÈger et al. (2001) No Case report Singleton pregnancy 46,XX (1) Kitamura et al. (2000) No 2 (2) 1 biochemical pregnancy and 1 miscarriage No information at 8 weeks Tachdjian et al. (2003) No Case report Twin pregnancy 46,XX (1)46,XY (1) 47,XXY: frozen±thawed ejaculated spermatozoa Bourne et al. (1997) No Case report Twin pregnancy 46,XX (1)46,XY (1) 47,XXY: fresh testicular spermatozoa Staessen et al. (1996); Tournaye et al. (1997) Yes 3 (3); 7 (5) 1 biochemical and 2 singleton pregnancies 2 healthy neonates Palermo et al. (1998) No 3 (2) Singleton and twin pregnancy 46,XY (2)46,XX (1) Reubinoff et al. (1998) Yes 5 (4) Singleton pregnancy 46,XY (1) Levron et al. (2000) No Not known (8) 1 triplet, 1 twin and 2 singleton pregnancies 46,XY (4)46,XX (3) Poulakis et al. (2001) No 2 (2) 2 singleton pregnancies 46,XY (1)46,XX (1) Friedler et al. (2001) No 5 (5) 2 singleton and 1 twin c pregnancy 4 healthy neonates Nodar et al. (1999) No Case report Twin pregnancy 46,XY (2) Kitamura et al. (2000) No 1 (1) Singleton pregnancy 46,XX (1) Greco et al. (2001) No Case report Twin pregnancy 46,XY (2) Yamamoto et al. (2002) No 12 (9) 1 twin and 3 singleton pregnancies 46,XY (2)46,XX (3) 47,XXY: frozen±thawed testicular spermatozoa Friedler et al. (2001) No 5 (5) Twin pregnancy Both healthy males Rosenlund et al. (2002) No Case report Singleton pregnancy 46,XY (1) a Number of couples in parentheses. b Number of children in parentheses. c Triplet with 47,XXY fetus reduced in the 14th gestational week. technique have shown varying incidences of normal spermatozoa ranging from 50.0 to 93.7% (Guttenbach et al., 1997; Estop et al., 1998; Levron et al., 2000) and an increased incidence of 24,XX and 24,XY hyperhaploid spermatozoa as compared with a control population (Foresta et al., 1998; Hennebicq et al., 2001; Yamamoto et al., 2002), while the incidence of 24,YY hyperploid spermatozoa was similar (Guttenbach et al., 1997) and disturbed 23,X/23,Y ratios (Guttenbach et al., 1997). These different studies in fact con rm that, in Klinefelter patients, there is an increased incidence of genetically imbalanced spermatozoa, though two different hypotheses have been formulated. The rst hypothesis is that 47,XXY spermatogonia may undergo meiosis to produce hyperhaploid spermatozoa (Guttenbach et al., 1997; Estop et al., 1998; Foresta et al., 1998; Bielanska et al., 2000; Hennebicq et al., 2001; Yamamoto et al., 2002); the second hypothesis is that the rare break-through patches of spermatogenesis in XXY males are due to the presence of normal XY germ cells but, as a result of the compromised testicular environment, these 46,XY germ cells are susceptible to meiotic abnormalities (Mroz et al., 1998). As the use of ICSI has become increasingly widespread, different centres have introduced infertility treatment for Klinefelter patients. Their reportsðthe majority of which are case reportsðrelate the centres' experience with fertility treatment of Klinefelter patients with ICSI but without the use of PGD, and this has resulted in the birth of healthy children (Table I). With the use of freshly ejaculated sperm, the birth of three healthy children has been reported, while two healthy children have been born after the use of frozen±thawed ejaculated sperm, and 26 healthy children have been born after the use of fresh testicular sperm. Finally, three healthy children were born following the use of cryopreserved-thawed testicular spermatozoa. One group (Ron-El et al., 2000a) reported a triplet gestation, one of which (a 47,XXY fetus) was reduced, while others (Kyono et al., 2001) reported a pregnancy following ICSI with fresh testicular sperm from a man with non-mosaic Klinefelter's syndrome and spinal cord injury. The outcome of this pregnancy was not documented however, as at the time of this writing the pregnancy was ongoing. In view of the possible risk of an increased number of gonosomes in their spermatozoa, anotherðmore safeðapproach is to offer these couples ICSI in combination with PGD using FISH technology, in order to enumerate the X and Y chromosomes in particular (Staessen et al., 1996; Reubinoff et al., 1998). To date, by using this approach of combining ICSI with fresh testicular sperm and PGD, three healthy children have been born (Table I). However, since these rst reports were made (Staessen et al., 1996; Tournaye et al., 1997; Reubinoff et al., 1998), a large number of non-mosaic Klinefelter patients have been treated with ICSI in combination with PGD at the authors' centre. The aim of the present review was to describe the fertility treatment in Klinefelter patients, and also to discuss the use of ICSI treatment with and without PGD. Several couples with non-mosaic Klinefelter's syndrome were treated with ICSI combined with PGD, and the genetic constitution of the embryos produced was compared with that of embryos obtained from control couples who 320

3 PGD after ICSI for 47,XXY patients underwent ICSI plus PGD in order to determine fetal gender with relation to sex-linked disease. Assisted reproduction techniques, PGD procedures and results Patients Between November 1994 and March 2002, sperm was obtained from 20 couples of which the husband had a 47,XXY karyotype. The subsequent 32 treatment ICSI cycles which were obtained, together with the data obtained from them, form the basis of the present report. The mean (6 SD) age of the female partners was years (maximum age 38 years), and all women had a normal fertility work-up. The non-mosaic 47,XXY karyotype in the patients was proven by an analysis of 15 to 30 metaphases with G-banding and/or an analysis of 50± 100 interphases with FISH analysis in peripheral blood preparations and/or broblasts. A weak mosaicism of 5±8% was detected after FISH analysis of 200 interphase lymphocytes in three patients; all of these patients consented to undergo PGD by FISH in order to determine the number of sex chromosomes if embryos were subsequently available for transfer. Another group of patients who underwent PGD to determine fetal gender with regard to sex-linked diseases was selected for comparison of the aneuploidy rate. This latter (control) group comprised 43 couples of which the female partner was aged <38 years (mean age years) and included 88 treatment cycles. The results of the latter patient group were published in part previously (Staessen et al., 1999). Sperm retrieval In general, spermatozoa were retrievable in ~50% of Klinefelter patients (Tournaye et al., 1996). The only predictive factor for successful sperm recovery in these patients was the histopathological nding, as for all other parametersð including ultrasonography and frequency of 46,XY in lymphocytes and buccal cellsðno signi cant difference was found between Klinefelter patients with successful sperm recovery and those in whom sperm recovery failed (Westlander et al., 2001). Therefore, sperm recovery is a crucial step in the fertility treatment of Klinefelter patients. Before patients were scheduled for infertility treatment, one or two of their sperm ejaculate samples were carefully evaluated for the presence of sperm cells by using high-speed centrifugation. If the presence of sperm cells was con rmed, the stimulation was planned. However, if no sperm cells were observed in the ejaculate, a testicular biopsy was scheduled (Tournaye et al., 1996; 1997). In cases where no spermatozoa were found after mechanical mincing of the biopsies, enzymatic treatment of the testicular tissue with collagenase type IV was employed (Crabbe et al., 1998) in order to maximize the chance of sperm retrieval. Attempts to freeze testicular sperm cells from non-obstructive males were successful (Verheyen et al., 1997); consequently, it was possible to freeze testicular sperm obtained from a diagnostic biopsy before a treatment cycle could be commenced. Two options exist in scheduling of the testicular biopsy. With the rst approach, the biopsy can be scheduled before starting hyperstimulation treatment, with subsequent freezing of the retrieved spermatozoa. Although this approach prevents the woman from being needlessly hyperstimulated, there is an estimated risk of 19.4% (Verheyen et al., 2002) that the retrieved sperm cells will not survive the freeze±thawing procedure. To counteract this risk, the patient should be scheduled for a back-up fresh biopsy sperm retrieval on the day of oocyte retrieval. The cryopreservation of testicular tissue obtained after diagnostic testicular biopsy is a routine procedure option at the authors' institution. Following an unsuccessful rst ICSI cycle with either fresh or frozen testicular spermatozoa, repeated testicular surgery for subsequent ICSI cycles may be avoided by using frozen specimens. This is important, as repeated biopsy retrieval may be dif cult in Klinefelter patients. The second approach option is to perform an initial testicular biopsy during a hyperstimulation treatment cycle. As sperm is generally recovered in only 50% of Klinefelter patients, this option could be proposed to couples agreeing to the use of donor sperm. ICSI was performed in 32 cycles of 20 couples, with sperm originating from a fresh ejaculate in one cycle, from a testicular biopsy in 21 cycles, and from a frozen±thawed testicular biopsy in 10 cycles (Table II). In two cycles, insuf cient spermatozoa were obtained after thawing of the testicular biopsy specimens in order to inject all the oocytes, and the two couples decided to have the remaining oocytes injected with donor spermatozoa rather than undergo repeat testicular biopsy. The results obtained from oocytes injected with donor sperm were excluded from the data analysis. Oocyte retrieval and ICSI procedure Ovarian stimulation was carried out by pituitary desensitizing with GnRH analogues (Buserelin, Suprefact; Hoechst, Brussels, Belgium) combined with hmg (Humegon; Organon, Oss, The Netherlands) or recombinant FSH (Gonal- F; Serono, Brussels, Belgium or Puregon; Organon) and hcg (Pregnyl, Organon; Profasi, Serono). Oocyte retrieval was carried out using ultrasound-guided puncture at 36 h after hcg administration. The cumulus±corona±oocyte complexes were placed in 25 ml droplets of medium and covered by lightweight paraf n oil. Before ICSI was carried out, the cumulus and corona cells were removed and nuclear maturation was assessed under an inverted microscope. The ICSI procedure was carried out as described previously (Van Steirteghem et al., 1998). The testicular spermatozoa were frequently found to be embedded in Sertoli cell cytoplasm, and had to be carefully extracted. For the injection, a motile sperm cell (if present) was aspirated into the injection pipette and injected into a metaphase II (MII) oocyte which had extruded the rst polar body. Injected oocytes were washed and incubated in 25 ml droplets of medium in a Petri dish at 37 Cin 321

4 C.Staessen et al. Table II. Results of fertility treatment of Klinefelter patients Origin of sperm cells (no. of cycles; no. of transfers) Number of: OCC retrieved (mean 6 SD per cycle) MII injected (mean 6 SD per cycle) 2PN (mean 6 SD per cycle) a Embryos biopsied (with diagnosis) Normal XX or XY (%) Embryos transferred (mean 6 SD per transfer) Positive hcg (with FHB) No. of deliveries Fresh ejaculate (77.8) 5 (4) 3 (75) 2 1 (1) 1 (n =1;1) Fresh TESE (85) 47 (55.3) 31 5 (3) 3 (n = 21; 18) ( ) ( ) ( ) ( ) Frozen TESE (24) 11 (45.8) 8 ( ) 2 (1) 1 c (n = 10; 7) ( ) ( ) b ( ) Total (n = 32; 26) 364 ( ) 310 ( ) 172 ( ) 119 (113) 61 (54.0) 41 ( ) 8 (5) 5 a Mean fertilization rate (%) per cycle. b From one patient only six of 12 oocytes were injected, and from one patient only one of 10 oocytes was injected with sperm from the Klinefelter patient and included in the data analysis. c Child liveborn preterm at 23 weeks, but did not survive. FHB = fetal heart beats; MII = metaphase II; OCC = oocyte±cumulus complex; 2PN = 2 pronuclei; TESE = testicular sperm extraction. an incubator under an atmosphere of 5% CO 2,5%O 2 and 90% N 2. The medium used for oocyte and embryo culture was subject to changes during the period of treatment, though since 1999 a sequential medium (G1-G2; Scandinavian IVF, Vitrolife, GoÈteborg, Sweden) has been used for all patients undergoing ICSI in combination with PGD. In total, 364 oocyte±cumulus complexes (OCCs) were retrieved, with a mean of OCC per cycle (Table II). Among these OCCs, 325 (89.3%) were at MII stage, and 310 of them were injected with sperm from Klinefelter patients. As mentioned earlier, in two patients insuf cient sperm was retrieved to inject all oocytes; in one of these patients only six of 12 MII oocytes were injected, while in the other patient only one of 10 MII oocytes was injected with sperm from the Klinefelter husband. The other oocytes were injected with donor sperm and excluded from further consideration in this report. Although when selecting sperm for microinjection the preference was to use a spermatozoon that had shown signs of motility, suf cient motile spermatozoa could not always be found for the oocytes retrieved; consequently, in some cycles ICSI was carried out with non-motile testicular spermatozoa. In three cycles, all the oocytes were injected with non-motile sperm cells, and in seven cycles some of the oocytes were injected with non-motile sperm cells due to a scarcity of motile sperm cells. In total, 247 (79.7%) oocytes were injected with a motile sperm cell, and 63 (20.3%) with a non-motile sperm cell. Fertilization was checked at 16±18 h after injection (Staessen et al., 1995). Normal fertilization was con rmed by the presence of two distinct pronuclei and polar bodies using microscopy (inverted microscope, original magni cation 3400). A mean fertilization rate of % per injected MII oocyte was obtained in all the cycles. There was no difference 322 in fertilization rate when either fresh sperm or sperm originating from frozen testicular-extraction (TESE) were used (see Table II). In three cycles, only non-motile sperm were injected; of the 26 injected MII oocytes, a total of 15 (57.7%) was fertilized (i.e. a mean of % for the three cycles). Among a total of 64 oocytes in seven cycles, 27 were injected with motile spermatozoa, and 15 (55.6%) were fertilized (i.e. mean % per patient); among 37 oocytes injected with non-motile sperm, 15 (40.5%) were fertilized (mean % per patient). By comparing the fertilization rate of motile versus non-motile sperm cells in sibling oocytes (n = 7 cycles), a tendency towards a higher fertilization rate in the group of oocytes injected with motile sperm cells was observed (Fisher's exact test, P = 0.3; NS). The likely reason for fertilization rates not being signi cantly different in this group was that not enough cases were involved. These data demonstrate that the selection of motile testicular spermatozoa is always preferable for ICSI, although as sperm production in non-mosaic Klinefelter patients is at best scarce, it is worthwhile using non-motile sperm cells for injecting the oocytes. These results were in agreement with fertilization rates obtained after the injection of motile (65%) versus non-motile (45%) testicular sperm cells in patients with complete azoospermia and normal karyotype (Nagy et al., 1998). The same group (Nagy et al., 1998) also showed that embryo quality at 2 days after ICSI was independent of either motile or non-motile testicular spermatozoa being microinjected; this indicated that when normal fertilization has occurred, the quality of the resulting embryos is generally independent of sperm factors (Nagy et al., 1995). Likewise, among 30 fertilized oocytes injected with non-motile sperm cells, 20 developed into embryos suitable for biopsy; a diagnosis was obtained in 15 of these, and four were normal and transferred.

5 PGD after ICSI for 47,XXY patients Table III. Number and quality of embryos for biopsy in patients with Klinefelter syndrome in relation to origin of the sperm, and in control patients Origin of sperm cells (no. of cycles; no. of cycles with biopsy) No. of 2PN (A) No. of embryos for biopsy (% A) <5-cell stage (n) 6- to 8-cell stage (n) Type A-B (%) Type C (%) Type A-B (%) Type C (%) Klinefelter patients Fresh ejaculate (n = 1; 1) (0) 2 (40) 1 (20) 2 (40) Fresh TESE (n = 21; 19) (13.3) 15 (16.7) 54 (60.0) 9 (10.0) Frozen TESE (n = 10; 9) (29.2) 3 (12.5) 12 (50.0) 2 (8.3) Total Klinefelter patients (69.2) * 19 (16.0) 20 (16.8) 67 (56.3) 13 (10.9) (n = 32; 29) Control patients (n = 88) (79.4) * 125 (20.7) 59 (9.8) 368 (60.9) 52 (8.6) * Fisher's exact test: P < As a consequence there was one clinical pregnancy. It was also reported that, for a small number of oocytes, quite similar fertilization rates were achieved regardless of whether motile or non-motile spermatozoa were injected (Ron-El et al., 2000b); among 14 oocytes injected with immotile spermatozoa, seven were fertilized and six cleaved, whereas among the eight oocytes injected with motile spermatozoa, seven were fertilized and cleaved. Both sets of embryos led to the establishment of a pregnancy. Embryo development and biopsy Oocytes with two pronuclei (2PN) were assessed on days 2 and 3 after injection for embryonic development, and embryos of grade A, B or C reaching at least the 5-cell stage on the morning of day 3 were biopsied. Type A embryos were de ned as those in which all the blastomeres were of an approximately equal size, without anucleate fragments. Type B embryos had blastomeres of equal or non-equal size and with anucleate fragments comprising a maximum 20% of the embryo volume, while type C embryos contained anucleate fragments as 20± 50% of their volume. Grade A, B, or C embryos with at least four blastomeres were biopsied on the morning of day 3 after microinjection. The selection criteria for embryo biopsy were similar to those used to decide whether an embryo was transferable on day 3 in the regular ICSI programme without PGD. Those embryos not suitable for biopsy were discarded. The same policy was applied as with embryos not considered for transfer. Before biopsy, the blastomeres were checked for the presence of nuclei. From the 6-cell stage onward, two blastomeres per embryo were removed (Van de Velde et al., 2000; De Vos and Van Steirteghem et al., 2001). Among 172 oocytes showing 2PN, 119 (69.2%) developed into embryos suitable for blastomere biopsy, and the remaining zygotes were arrested or severely delayed on day 3. In three cycles, no embryos suitable for biopsy were obtained, despite fertilization. In two cycles using fresh testicular sperm, ve and two zygotes were obtained respectively, but none of these could be considered for biopsy. In one cycle the only oocyte injected with frozen±thawed testicular sperm was fertilized, but fragmented on day 3 of development. Finally, among 29 of the 32 cycles, embryos were available for biopsy; cell stages and embryo quality for biopsy as de ned by morphological grade are summarized in Table III. Of these embryos, 32.8% had less than six cells, and 67.2% had at least six cells. As mentioned earlier, one group of patients undergoing PGD for sex-linked disease were added retrospectively (as controls) for comparison with the study group. In the control group (see Table III), a signi cantly higher proportion of zygotes (79.4%) developed into embryos suitable for biopsy as compared with the Klinefelter patients (69.2%; Fisher's exact test, P < 0.01), although the distribution of the different grades of embryos for biopsy was not signi cantly different between the control and Klinefelter subjects. One patient with a mosaic Klinefelter karyotype was reported to have a normal fertilization rate after ICSI; however, there was a high incidence of cleavage failure (44%) after pronuclei were observed (Bourne et al., 1995). These results further con rmed that spermatozoa recovered either from the ejaculate or by testicular biopsy from non-mosaic 47,XXY males can induce normal fertilization and cleavage following ICSI, though the cleavage rate may be impaired. FISH procedure The individually biopsied blastomeres were spread onto a Superfrost Plus glass slide (Kindler GmbH, Freiburg, Germany) using 0.01 mol/l HC1/0.1% Tween 20 solution (Coonen et al., 1994; Staessen et al., 1996). Both blastomeres from the same embryo were xed on the same slide, in very close proximity. The FISH procedure was used as described previously (Staessen et al., 1996) and, over a period of time, has included the use of several different probe mixtures. For the rst three PGD cycles, double target FISH was performed using directly labelled DNA probes speci c for chromosomes X (Alpha 323

6 C.Staessen et al. Table IV. Chromosomal abnormalities in embryos of couples with Klinefelter syndrome and control group in relation to the chromosomes analysed Variable Klinefelter syndrome Control Age <38 years Age <38 years No. of embryos analysed for chromosomes XY 4 Not done No. of normal embryos (%) 4 (100) Not done No. of embryos analysed for chromosomes XY, No. of normal embryos (%) 35 (53.0) 241 (76.5) No. of embryos analysed for chromosomes XY, 18, 21 Not done 54 No. of normal embryos (%) Not done 43 (79.6) No. of embryos analysed for chromosomes XY, 13, 18, No. of normal embryos (%) 21 (52.5) 133 (82.6) No. of embryos analysed for chromosomes XY, 13, 16, 18, 21, No. of normal embryos (%) 1 (33.3) 29 (60.4) Total number of embryos analysed Total number of normal embryos (%) 61 (54.0) a 446 (77.2) a a P < 0.01 (contingency table). Satellite DNA probe, Spectrum Green; Vysis, Inc., Downers Grove, IL, USA) and Y (Alpha Satellite DNA probe, Spectrum Orange; Vysis, Inc.) (Staessen et al., 1996). For the next 13 PGD cycles, a triple-target FISH technique was performed using directly labelled DNA probes speci c for chromosomes X (Alpha Satellite DNA, Spectrum Green; Vysis, Inc.), Y [Alpha Satellite III DNA (DYZ1 locus), Spectrum Orange; Vysis, Inc.] and 18 (Alpha Satellite DNA, 1:1 mixture Green/ Orange spectrum; Vysis, Inc.). In the remaining 15 cycles, probes for chromosomes XY, 13, 18 and 21 (DXZ1, Spectrum Blue; DYZ3, Spectrum Gold; LSI13, Spectrum Red; D18Z1, Spectrum Aqua; LSI21 Spectrum Green; Multivision PGT Probe Panel; Vysis, Inc.) were applied. An aliquot (0.2 ml) of the probe solution was added to the nuclei, covered with a round coverslip (4 mm diameter), denatured for 5 min at 73 C and left to hybridize for between 4 h and overnight at 37 C in a moist chamber. After washing in 0.43 standard saline citrate (SSC) at 71 C for 2 min, antifade solution (Vectashield) was added and uorescence signals were evaluated. The nuclei were then examined using a Zeiss Axioskop uorescence microscope with the appropriate lter sets. The FISH images were captured with a computerized system, and the results interpreted by two independent observers. In one cycle, a two-round FISH procedure was performed which allowed the detection of chromosomes XY, 13, 18, 21 (round 1) and 16, 22 (round 2). Following the analysis of the rst set of probes, the coverslips were gently removed and the slides rinsed in 13 phosphate-buffered saline at room temperature, denatured in SSC for 7 min at 75 C, and then dehydrated (70, 90, 100 and 100% ethanol at ±18 C, 40 s each). The second hybridization solution was prepared by mixing a probe for chromosome 16 (Satellite II DNA/D16Z3 probe, Spectrum Orange; Vysis, Inc.) and a probe for chromosome 22 (LSI 22, 22q11.2, Spectrum Green; Vysis, Inc.). The probes were denatured separately in a hot waterbath at 75 C for 5 min. An 324 aliquot (0.2 ml) of the probe solution was then added to the nuclei, covered with a round coverslip (4 mm diameter), sealed with rubber cement and then hybridized overnight in a water bath at 37 C. Finally, the slides were washed for 2 min in 0.43 SSC at 73 C and 23 SSC/0.1% Nonidet P40 for 60 s at room temperature. The washed slides were then mounted with DAPI in antifade solution, and analysed. Following biopsy and FISH procedure, a FISH result was obtained in 113 of 119 (95.0%) embryos available. A normal result was obtained for the chromosomes analysed in 61 of the 113 embryos (54.0%). Three out of four (75%) embryos obtained with fresh ejaculate were normal, 47 out of 85 (55.3%) embryos obtained with fresh testicular sperm were normal, and 11 out of 24 (45.8%) embryos obtained with frozen testicular sperm cells were normal. Although the groups were very small, there was no inter-group difference with regard to the percentage of normal embryos according to the different origins of sperm used. Embryo transfer and outcome During the study period, the policy was changed with regard to the day of transfer, from day 3 to day 5. This allowed the FISH procedure to be performed with a greater number of probes in two consecutive FISH rounds. The number of embryos transferred was also in line with a policy to transfer a maximum of two embryos in patients aged <37 years if the embryo quality was good. Transfer on day 5 also allowed the selection of those embryos which reached the compacting or blastocyst stage on day 5. Spare, genetically normal embryos of suf cient morphological quality were cryopreserved (Van den Abbeel et al., 1997). Implantation was con rmed when two hcg concentrations of >10 U/l were measured at least 10 days after embryo transfer. Clinical pregnancy was de ned by an intrauterine gestational sac with a fetal heartbeat seen by vaginal ultrasound at least 6 weeks after embryo transfer. PGD is a novel technique, and it is recommended that in the case of pregnancy

7 PGD after ICSI for 47,XXY patients Table V. Frequency of abnormalities for each chromosome for patients with Klinefelter syndrome and for controls Abnormality Klinefelter(age <38 years) Control(age <38 years) I. Sex chromosomal abnormalities No. of sex chromosome abnormalities/no. of embryos analysed for this chromosome (%) 15/113 a (13.2) 18/578 a (3.1) Monosomy XO 7 * 10 Monosomy OY 2 0 Trisomy XYY 2 1 Trisomy XXX 1 1 Trisomy XXY 0 4 Mosaic XY/XXY 2 1 Mosaic XY/XYY 1 0 Mosaic XX/XO 0 1 II. Autosomal abnormalities No. of chromosome 13 abnormalities/no. of embryos analysed for this chromosome (%) 3/43 (7.0) 5/209 (2.4) Monosomy Trisomy 13 2 ** 2 No. of chromosome 16 abnormalities/no. of embryos analysed for this chromosome (%) 0/3 4/48 (8.3) Monosomy Trisomy No. of chromosome 18 abnormalities/no. of embryos analysed for this chromosome (%) 8/109 b (7.3) 12/578 b (2.1) Monosomy Trisomy 18 4 ** 1 Mosaic monosomy 18/disomy No. of chromosome 21 abnormalities/no. of embryos analysed for this chromosome (%) 5/43 c (11.6) 8/263 c (3.0) Monosomy 21 3 * 6 Trisomy Mosaic disomy 21/trisomy No. of chromosome 22 abnormalities/no. of embryos analysed for this chromosome (%) 1/3 (33.3) 1/48 (2.1) Monosomy Trisomy III. Ploidy status abnormalities No. of haploid embryos/total no. of embryos analysed (%) 6/113 d (5.3) 4/578 d (0.7) No. of triploid embryos/total no. of embryos analysed (%) 4/113 (3.5) 9/578 (1.6) No. of tetraploid embryos/total no. of embryos analysed (%) 2/113 (1.7) 12/578 (2.1) IV. Combined abnormalities No. of embryos with combined abnormalities/ total no. of embryos analysed (%) 10/113 (8.8) 59/578 (10.2) *Including the double monosomy X-21: in fact counted twice. **Including the double trisomy 13±18: in fact counted twice. a, b, c, d : Fisher's exact test: P < the couple should undergo prenatal diagnosis in order to con rm the PGD diagnosis, either by chorionic villus sampling or by amniocentesis. Among the pregnancies obtained to date, only one couple effectively decided to perform amniocentesis; the fetus was normal and the PGD result con rmed. Clearly, as experience with PGD is increased and accurate estimates of error risks become available, the attitude to prenatal diagnosis will be reconsidered. The introduction of techniques such as comparative genomic hybridization, which enable all chromosomes to be investigated, will remove the risk of all chromosome imbalances. A total of 41 embryos was transferred (see Table II) in 26 transfer procedures (mean embryos per transfer). Embryo transfer could not be performed in three patients, this being due to an absence of normal embryos in two cases, and of poor embryo quality (but genetic normality) in one case. A total of eight cycles with positive hcg was obtained from the 26 transfers; three of these were preclinical abortions and ve were ongoing. This provided an ongoing pregnancy rate of 15.6% per cycle, or 19.2% per transfer. The implantation rate with fetal heart activity was 12.8% per transferred embryo. One patient delivered prematurely at 23 weeks gestation, most likely due to chorioamnionitis; the child was stillborn at delivery. The four other pregnant patients delivered healthy babies (two girls, two boys) at term. To date, among the 20 couples in which sperm were found, four of them delivered (live birth rate 20%). Which genetic abnormalities are found at diagnosis? As mentioned earlier, 54.0% of the embryos from Klinefelter patients were found to be normal, with an almost equal sex ratio (32/61 female; 29/61 male). The numbers of embryos analysed with the different probe mixtures, together with details of embryos 325

8 C.Staessen et al. Table VI. Results of embryos at biopsy and reanalysis of the non-transferred or non-cryopreserved embryos At biopsy FISH results Reanalysed embryos No. of embryos Blastomere 1 Blastomere 2 No. of embryos reanalysed FISH results 32 normal female 4 4: normal female 29 normal male 6 6: normal male 6 monosomy X0 5 3: monosomy X0 1: disomy XX * 1: chaotic 1 double monosomy X : double monosomy X-21 2 monosomy 0Y 2 2: monosomy 0Y 2 trisomy XYY 2 1: trisomy XYY 1: mosaic XYYY/XY/XYY 1 trisomy XXX 1 1: mosaic: monosomy X0 /trisomy XXX 2 XY XXY 1 1: mosaic XY/XXY 1 XY XYY 1 1: mosaic XY1818 / XYY monosomy : monosomy 13 1 trisomy : trisomy 13 4 monosomy : monosomy 18 2: mosaic: disomy 18 / monosomy 18 3 trisomy : double trisomy 18-XYY 1 double trisomy 13 ±18 1 1: double trisomy 13±18 2 monosomy : mosaic monosomy 21/disomy 21/ trisomy 21/ 1 trisomy : trisomy 21 1 disomy 21 monosomy : mosaic monosomy 21/disomy 21 1 monosomy haploid X 4 2: mosaic XX diploid/x haploid; 2: chaotic 2 haploid Y 2 2: chaotic 4 triploid 4 4: triploid 2 tetraploid 1 1: tetraploid 10 combined abnormalities 6 2: normal diploid * ; 4: chaotic * Embryos considered as not con rmed. found to be normal for the chromosomes tested are listed in Table IV. Abnormalities related to the gain or loss of a speci c chromosome, and to the ploidy status of the embryo (haploid, triploid or tetraploid) are detailed in Table V. An abnormality of the gonosomes was apparent in 15 of the 113 (13.2%) embryos tested, and of the autosomes in 17 of 109 (15.6%). Likewise, 12 of 113 (10.6%) embryos showed an abnormality of ploidy status, and 10 of 113 (8.8%) showed combined abnormalities. Are embryos generated by Klinefelter patients at increased genetic risk? In comparison with controls, Klinefelter patients showed a signi cantly higher percentage of abnormal embryos (Fisher's exact test; P < 0.01). The prevalence of sex chromosome abnormalities was only 3.1% in FISH for sex-linked disease group, compared with 13.2% in Klinefelter patients (Fisher's exact test; P < 0.01), while the prevalence of autosomes was 30 of 578 embryos (5.2%) in controls and 17 of 109 (15.6%) in Klinefelter patients (Fisher's exact test; P < 0.01). If data for each autosome chromosome are compared separately, then a signi cantly increased risk was observed for chromosomes 18 and 21 (Fisher's exact test; P < 0.01). Moreover, among the control subjects 25 of 578 embryos (4.3%) had abnormalities of ploidy status compared with 12 of 113 (10.6%) (P < 0.01) in Klinefelter patients. Finally, in the control group 59 of 578 embryos (10.2%) had combined abnormalities compared with 10 of 113 (8.8%) in the Klinefelter group. One group (Magli et al., 2002) reported their experience with PGD in couples with an altered karyotype due to gonosomal mosaicism, and focused on the chromosomal condition of embryos generated. Some 63% of the embryos were chromosomally abnormal, and the incidence of aneuploid mosaics was higher as compared with PGD patients with normal karyotype of the same age. This suggested that constitutional carriers of sex chromosome mosaicism are predisposed to autosomal mosaicism of embryos. Although few data were generated, the incidence of chromosomally abnormal embryos was slightly higher when the woman was the carrier. These authors concluded that their ndings support a predisposition in patients with gonosomal mosaicism to give rise to different cell lines, possibly due to disturbances and malfunctioning of the mechanisms entering cell division. Analysis of non-transferred and non-cryopreserved embryos After PGD and embryo transfer, cells from embryos which were classi ed as genetically normal but morphologically unsuitable for transfer or cryopreservation (n = 10) or as genetically abnormal (n = 52) were spread as a whole as described previously (Staessen and 326

9 Van Steirteghem, 1997), and FISH was carried out using the same probe mixture as was used for the diagnosis. All patients involved consented for further research to be carried out on these embryos. The results were compared with the one-cell diagnosis in order to verify the accuracy of the technique. In total, 62 embryos were spread for reanalysis, of which 527 blastomeres were counted. A FISH result was obtained for 426 blastomeres from 51 embryos (Table VI). The remaining normal embryos (n = 10) which could not be frozen due to poor quality were reanalysed. In all 10 embryos the normal status was con rmed in most of the nuclei. A reanalysis was obtained for ve of the six embryos diagnosed as monosomy X0; in three cases a uniform X0 embryo was con rmed, one embryo was found to be XX diploid (FISH diagnosis not con rmed), and one was chaotic. The diagnosis was con rmed in one embryo with a double monosomy for X and 21. Both 0Y diploid embryos were found to be uniform 0Y diploid embryos. A reanalysis was obtained of both XYY embryos; one embryo was con rmed to be XYY uniformly, while in the other embryo XYY was found to originate from a XYY conception followed by postzygotic non-disjunction resulting in a XYYY and a XY cell line. The trisomic XXX may have arisen from an XX embryo at conception followed by post-zygotic non-disjunction leading to X0 and XXX cell lines. In two embryos, one of the two blastomeres analysed showed a normal XY pattern, and the other an abnormal XXY pattern; both embryos were spread. FISH results were obtained from one embryo only. The XY/XXY mosaic embryo was most likely the result of a XXY conception followed by post-zygotic loss of an X chromosome in one cell line. An analogous situation pertained to the XY/XYY mosaic embryo. Here, a conception of an XYY embryo with subsequent loss of a Y chromosome in one cell might have occurred, or an XY embryo at conception followed by post-zygotic non-disjunction involving a Y chromosome leading to X0/XY/XYY cell lines from which the X0 cell line was lost during the procedure. Intracytoplasmic fertilization of oocytes with a Klinefelter male's 24,XY- or 24,XXbearing spermatozoa, could theoretically produce a 47,XXY or a 47,XXX embryo. These results indicate that indeed, 47,XXY or 47,XXX embryos were formed. The results were given for the autosomal abnormalities and explanations similar to those for the sex chromosome abnormalities are valid. To the present authors' knowledge, only two other groups have reported FISH analysis on embryos of 46,XY/47,XXY or 47,XXY Klinefelter patients. In the rst study (Bielanska et al., 2000), results were reported on FISH analysis with DNA probes speci c for chromosomes X, Y and 18 on 10 spare embryos from fertility treatment of a 46,XY/47,XXY Klinefelter patient. The data revealed that only three of 10 embryos were normal for the chromosomes testedðone embryo with an XX1818 and two embryos with an XY1818 pattern. The abnormalities detected included ve chaotic mosaic embryos and two diploid mosaic embryos with the majority of blastomeres normal for the chromosomes tested. The second study (Reubinoff et al., 1998) reported on PGD with probes for chromosomes X, Y and 18 in three embryos from two patients. One embryo was diagnosed as normal and transferred; this resulted in the birth of a karyotypically normal neonate. The biopsied blastomere from the second embryo had an abnormal XX18 constitution. The blastomere from the third embryo was also found to contain an abnormal pattern, XXY1818. Spreading of the remainder of the cells from the above two embryos revealed nuclei with various X and Y patterns, consistent with chaotic cell division. In contrast with the results of the present study, none of the embryos analysed in either study showed a XXY1818 or XXX1818 pattern, but of course both studies were dealing with a limited number of analysed embryos. The present data and that from both other reports on embryos from Klinefelter patients demonstrate that the incidence of chromosomal mosaicism in in-vitro-fertilized human embryos is substantial. When PGD is attempted, the patients should be consulted regarding the limitations of aneuploidy detection by this experimental technique. In some cases, blastomere analysis at the cleavage stage will not be representative of the whole embryo, due to the high frequency of chromosomal mosaicism in human embryos (Munne and Cohen, 1993; Harper et al., 1995). However, the present data show that on the basis of the results at diagnosis and after PGD reanalysis, the initial diagnosis could not be con rmed in only three of 51 (5.9%) embryos and that, on the basis of the PGD result, the embryos which could have been transferred were actually rejected for transfer. Conclusion PGD after ICSI for 47,XXY patients It is generally accepted that the introduction of ICSI has constituted a breakthrough in the treatment of male infertility. Even patients considered azoospermic but with focal spermatogenesis in the testis, such as those with non-mosaic 47,XXY Klinefelter syndrome, have been able to bene t from the ICSI technique. Furthermore, ICSI of the patient's spermatozoa induced fertilization, produced a high percentage of cleavage-stage embryos, and led to implantation and ongoing pregnancy. All neonates that have been reported as being born after ICSI without PGD using spermatozoa from patients with non-mosaic Klinefelter syndrome are normal. One fetus conceived by spermatozoa recovered from a man with non-mosaic Klinefelter syndrome was of 47,XXY karyotype, and the embryo was reduced at week 14 (Ron-El et al., 2000a). The FISH method with directly labelled DNA probes speci c for the X and Y chromosomes constitutes an ef cient and rapid procedure to determine the exact number of sex chromosomes present in one or two blastomeres of a preimplantation embryo. Since PGD by FISH technology was available at the present authors' institution, a policy was adopted which proposed that patients should combine ICSI treatment with PGD, particularly in order to enumerate the sex chromosomes before transfer (Staessen et al., 1996). The experience of combining ICSI with PGD indicates that there was a signi cant fall in the rate of normal embryos for couples with Klinefelter's syndrome compared with control patients undergoing PGD for gender determination and using ejaculated sperm. Indeed, a signi cantly increased risk of abnormalities for the sex chromosomes as well as for the autosomes was observed; for each autosome separately, this reached signi cance level only for chromosomes 18 and 21. A much higher frequency of disomy 21 was found in the spermatozoa of a Klinefelter patient than in those of control patients (Hennebicq et al., 2001). Any child conceived by ICSI using this sperm will thus have a proportionally higher risk of trisomy 21. Hennebicq explained this by suggesting that, ``The 327

10 C.Staessen et al. most likely reason for the high rate of disomy 21 in our XXY patient is that the abnormal sex chromosome content disturbs the meiotic segregation of some chromosomal pairs, possibly via the presence of an abnormal or absent sex vesicle. Close association of chromosome 21 with one or both sex chromosomes during meiosis could lead to a disturbance of chromosome 21 segregation in the case of an abnormal sex vesicle. The observation provides evidence of the possibility of an interchromosomal effect in patients with Klinefelter's syndrome that results in a higher than normal risk of trisomy 21 in their children?'' The high proportion of normal fetuses that develop from the implantation of embryos generated by fertilization of oocytes with spermatozoa recovered from men with Klinefelter's syndrome may be due to the large percentage of normal (23,X or 23,Y) spermatozoa produced by these Klinefelter patients (Guttenbach et al., 1997; Estop et al., 1998; Levron et al., 2000), though most of the studies investigated only a limited number of chromosomes. Another explanation is the possible reduced implantation potency of the genetically abnormal embryos. It is clear that there is an increased risk of sex and autosomal chromosomal abnormal embryos obtained in Klinefelter patients when compared to patients with normal karyotype and normal spermatogenesis. A possible approach is to transfer all embryos available in Klinefelter patients, assuming that only the best ones will implant. Although this approach is reasonable, it is in contradiction with the general policy of limiting the numbers of embryos for transfer, and in any case does not remove the risk of producing a child with a chromosome abnormality. Without PGD, the chance of selecting and transferring abnormal embryos is high because even embryos with normal morphology have a distinct percentage of abnormalities (Harper et al., 1995; Munne et al., 1995). Moreover, in case of pregnancy there is an indication for prenatal diagnosis with the potential risk of procedure-related miscarriage and, in the case of an abnormal result, termination of the pregnancy. Finally, by transferring genetically abnormal embryos, genetically normal ones will be frozen; as a consequence, since only 50% of embryos will survive thawing, the patients' chances are reduced yet again. With PGD, the identi cation of abnormalities in a cohort of morphologically goodquality embryos prevents the transfer of those embryos that are destined either not to implant or to abort spontaneously. One argument against PGD (Hardy et al., 1990) is that embryo biopsy might affect the viability of these precious embryos which have been generated after ICSI, sometimes with extremely rare sperm. As yet, however, no convincing argument has been produced that would demonstrate a possible dramatic effect of biopsy on the implantation potency of the embryo. The incidence of chromosomal abnormalities in epididymal and testicular sperm retrieved from azoospermic patients undergoing ICSI has been quanti ed (Palermo et al., 2002). The overall aneuploidy rate, analysed by FISH for chromosomes XY, 18 and 21, of 11.4% in men with non-obstructive azoospermia was signi cantly higher than the rate of 1.8% detected in epididymal sperm from men with obstructive azoospermia, and also higher than the rate of 1.5% found in ejaculated sperm. No signi cant difference was found between the epididymal and ejaculated samples. When the chromosomal abnormalities were analysed, gonosomal disomy was the most recurrent abnormality in both obstructive and non-obstructive azoospermic patients, while autosomal disomy was the most frequent in ejaculated sperm. These ndings point to a higher incidence of sperm chromosomal abnormalities in sperm of non-obstructive azoospermic men, where sex chromosome aneuploidy appears to be the most common. The question arising here is whether the increased abnormalities in embryos from Klinefelter patients are related to the 47,XXY karyotype, or to the use of testicular sperm of azoospermic patients. For Klinefelter patients in particular this would imply that the rare break-through patches of spermatogenesis in XXY males may be due to the presence of normal XY germ cells, but as a result of the compromised testicular environment these 46,XY germ cells are susceptible to meiotic abnormalities, including non-disjunction of the sex chromosomes (Mroz et al., 1998) and the autosomes (Hennebicq et al., 2001). A comparative analysis of the incidence and type of chromosomal abnormalities between Klinefelter patients and non-obstructive azoospermic males will provide more information regarding possible mechanisms at the origin of chromosomal abnormalities. In conclusion, at the present authors' institution, broad genetic counselling is offered to couples with non-mosaic Klinefelter's syndrome, and the use of ICSI in combination with PGD is recommended. Ultimately, however, the nal decision must be made by the couples concerned. Acknowledgements The authors thank the clinical, scienti c, nursing, and technical staff of the Centre for Reproductive Medicine, and especially the colleagues of the microinjection and IVF laboratory. They are also very grateful to Mrs Marleen CarleÂ, Sylvie Mertens and Griet Meersdom for technical assistance with the FISH studies, and to Mrs Ines Devolder of the University Language Centre for correcting the English text. Grants from the Belgian Fund for Medical Research are kindly acknowledged. References Bielanska, M., Tan, S.L. and Ao, A. (2000) Fluorescence in-situ hybridization of sex chromosomes in spermatozoa and spare preimplantation embryos of a Klinefelter 46,XY/47,XXY male. Hum. Reprod., 15, 440±444. Bourne, H., Richings, N., Harari, O., Watkins, W., Speirs, A.L., Johnston, H., and Gordon Baker, H.W. (1995) The use of intracytoplasmic sperm injection for the treatment of severe and extreme male infertility. Reprod. Fertil. Dev., 7, 237±245. Bourne, H., Stern, K., Clarke, G., Pertile, M., Speirs, A. and Gordon Baker, H.W. (1997) Delivery of normal twins following the intracytoplasmic injection of spermatozoa from a patient with 47,XXY Klinefelter's syndrome. Hum. Reprod., 12, 2447±2450. Coonen, E., Dumoulin, J.C.M. Ramaekers, F.C.S. and Hopman, A.H.N. (1994) Optimal preparation of preimplantation embryo interphase nuclei for analysis by uorescent in situ hybridization. Hum. Reprod., 9, 533±537. CrabbeÂ, E., Verheyen, G., Silber, S., Tournaye, H., Van de Velde, H., Goossens, A. and Van Steirteghem, A. (1998) Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia. Hum. Reprod., 13, 2791±2796. CruÈger, D., Toft, B., Agerholm, I., Fedder, J., Hald, F. and Bruun-Petersen, G. (2001) Birth of a healthy girl after ICSI with ejaculated spermatozoa from a man with non-mosaic Klinefelter's syndrome. Hum. Reprod., 16, 1909± DeVos, A. and Van Steirteghem, A. (2001) Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat. Diagn., 21, 767±780. Estop, A.M., MunneÂ, S., Cieply, K.M., Vandermark, K.K., Lamb, A.N. and Fisch, H. (1998) Meiotic products of a Klinefelter 47,XXY male as determined by sperm uorescence in-situ hybridisation analysis. Hum. Reprod., 13, 124±

Article Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening?

Article Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening? RBMOnline - Vol 12. No 3. 2006 334-339 Reproductive BioMedicine Online; www.rbmonline.com/article/1947 on web 25 January 2006 Article Which patients with recurrent implantation failure after IVF benefit

More information

Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients

Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,

More information

Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years

Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years Peter Platteau, M.D., a Catherine Staessen, Ph.D., a,b An Michiels, M.Sc., b Andre Van Steirteghem, Ph.D., a Inge

More information

Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos

Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos RBMOnline - Vol 5. No 3. 306 312 Reproductive BioMedicine Online; www.rbmonline.com/article/699 on web 12 September Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation

More information

Article TESE ICSI in patients with non-mosaic Klinefelter syndrome: a comparative study

Article TESE ICSI in patients with non-mosaic Klinefelter syndrome: a comparative study RBMOnline - Vol 18. No 6. 2009 756-760 Reproductive BioMedicine Online; www.rbmonline.com/article/3892 on web 17 April 2009 Article TESE ICSI in patients with non-mosaic Klinefelter syndrome: a comparative

More information

Assisted reproductive technology

Assisted reproductive technology Assisted reproductive technology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Vol. 62, No.4, October 1994 Printed on acid-free paper in U. S. A. Cryopreservation of supernumerary

More information

Identification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis

Identification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis Ye et al. / J Zhejiang Univ SCI 2004 5(10):1249-1254 1249 Journal of Zhejiang University SCIENCE ISSN 1009-3095 http://www.zju.edu.cn/jzus E-mail: jzus@zju.edu.cn Identification of embryonic chromosomal

More information

S.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1

S.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1 Human Reproduction vol.15 no.9 pp.2003 2007, 2000 Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation

More information

Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia

Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia Human Reproduction vol.13 no.10 pp.2791 2796, 1998 Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia E.Crabbé

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Abstract. Introduction. Materials and methods. Patients and methods

Abstract. Introduction. Materials and methods. Patients and methods RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos

More information

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE

More information

Sherman J.Silber 1,3, Zsolt Nagy 2, Paul Devroey 2, Michel Camus 2 and André C.Van Steirteghem 2

Sherman J.Silber 1,3, Zsolt Nagy 2, Paul Devroey 2, Michel Camus 2 and André C.Van Steirteghem 2 Human Reproduction vol.12 no.12 pp.2693 2700, 1997 The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters Human Reproduction Vol.17, No.10 pp. 2600 2614, 2002 Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters Maryse Bonduelle 1,3, Elvire

More information

H.Van de Velde 1, Z.P.Nagy, H.Joris, A.De Vos and A.C.Van Steirteghem

H.Van de Velde 1, Z.P.Nagy, H.Joris, A.De Vos and A.C.Van Steirteghem Human Reproduction vol.12 no.10 pp.2246 2250, 1997 Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection

More information

Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes

Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes RBMOnline - Vol 6. No 2. 226 231 Reproductive BioMedicine Online; www.rbmonline.com/article/794 on web 28 January 2003 Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

Preimplantation Genetic Testing

Preimplantation Genetic Testing Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical

More information

Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo

Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Original Article Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Rita de Cassia Savio Figueira, M.Sc. 1, Amanda Souza Setti, B.Sc. 1,, Daniela Paes Almeida Ferreira Braga,

More information

Indications for chromosome screening Dagan Wells, PhD, FRCPath dagan.wells@obs-gyn.ox.ac.ukgyn.ox.ac.uk Chromosome imbalance (aneuploidy) Uncontroversial data The incidence of aneuploidy Aneuploidy is

More information

Novel Technologies for Selecting the Best Sperm for IVF and ICSI

Novel Technologies for Selecting the Best Sperm for IVF and ICSI Novel Technologies for Selecting the Best Sperm for IVF and ICSI Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA Testing The Sperm Population NOW Sperm DNA testing Although we are

More information

Date of birth: / / Date of birth: / /

Date of birth: / / Date of birth: / / Name (Female): Partner s name: Date of birth: / / Date of birth: / / IVF Number: Background Information An individual s genetic information is packaged into strings of DNA called chromosomes. Normal human

More information

Chromosomal Aneuploidy

Chromosomal Aneuploidy The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common

More information

Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection

Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection Human Reproduction vol.14 no.3 pp.726 730, 1999 Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection S.Kahraman 1,4, C.Akarsu 1, G.Cengiz 1, K.Dirican 1,

More information

Extended sperm preparation: an alternative to testicular sperm extraction in non-obstructive azoospermia

Extended sperm preparation: an alternative to testicular sperm extraction in non-obstructive azoospermia Human Reproduction vol.12 no.6 pp.1222 1226, 1997 Extended sperm preparation: an alternative to testicular sperm extraction in non-obstructive azoospermia R.Ron-El 1, D.Strassburger, S.Friedler, D.Komarovski,

More information

Fertility with testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermic men

Fertility with testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermic men Human Reproduction vol. no.4 pp.75-70, 199 Fertility with testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermic men Semra Kahraman 1-4, Suat Ozgur 2, Cengiz Alatas.

More information

Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis

Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis Catherine M. DeUgarte, M.D., a Man Li, M.D., Ph.D., b Mark Surrey, M.D., c Hal Danzer,

More information

Outline. History of sperm freezing. Testicular tissue: When and how should it be cryopreserved?

Outline. History of sperm freezing. Testicular tissue: When and how should it be cryopreserved? Testicular tissue: When and how should it be cryopreserved? Greta Verheyen Centre for Reproductive Medicine UZ Brussel, Belgium ESHRE Campus Granada 25-26 March 2010 Outline History of sperm freezing Indications

More information

Date of birth: / / Date of birth: / /

Date of birth: / / Date of birth: / / Name (Female): Partner s name: Date of birth: / / Date of birth: / / IVF Number: Background Information An individual s genetic information is packaged into strings of DNA called chromosomes. Normal human

More information

Problem Challenge Need. Solution Innovation Invention

Problem Challenge Need. Solution Innovation Invention Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978

More information

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS What is preimplantation genetic testing for aneuploidy? (an abnormal number of chromosomes; PGT-A) is a testing technique that can help choose embryos that appear

More information

Chromosome pathology

Chromosome pathology Chromosome pathology S. Dahoun Department of Gynecology and Obstetrics, University Hospital of Geneva Cytogenetics is the study of chromosomes and the related disease states caused by abnormal chromosome

More information

Rejuvenation of Gamete Cells; Past, Present and Future

Rejuvenation of Gamete Cells; Past, Present and Future Rejuvenation of Gamete Cells; Past, Present and Future Denny Sakkas PhD Scientific Director, Boston IVF Waltham, MA, USA Conflict of Interest I have no conflict of interest related to this presentation.

More information

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their

More information

CYTOGENETICS Dr. Mary Ann Perle

CYTOGENETICS Dr. Mary Ann Perle CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided

More information

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde Human Reproduction vol.14 no.1 pp.65 69, 1999 Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure

More information

SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO

SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO L. Gianaroli, C.M. Magli, A.P. Ferraretti Reproductive Medicine Unit - Via Mazzini, 12-40138 Bologna sismer@sismer.it WOMEN S REPRODUCTIVE HEALTH IN THE

More information

Ewa Wiland 1, Calvin J. Hobel 2, David Hill 3 and Maciej Kurpisz 1 * INTRODUCTION

Ewa Wiland 1, Calvin J. Hobel 2, David Hill 3 and Maciej Kurpisz 1 * INTRODUCTION PRENATAL DIAGNOSIS Prenat Diagn 2008; 28: 36 41. Published online in Wiley InterScience (www.interscience.wiley.com).1899 Successful pregnancy after preimplantation genetic diagnosis for carrier of t(2;7)(p11.2;q22)

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Reproductive Technology, Genetic Testing, and Gene Therapy

Reproductive Technology, Genetic Testing, and Gene Therapy Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples

More information

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.

More information

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC

More information

Original Policy Date

Original Policy Date MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to

More information

Testosterone Therapy-Male Infertility

Testosterone Therapy-Male Infertility Testosterone Therapy-Male Infertility Testosterone Therapy-Male Infertility Many men are prescribed testosterone for a variety of reasons. Low testosterone levels (Low T) with no symptoms, general symptoms

More information

Pre-implantation genetic diagnosis in Hong Kong. Ng, EHY; Lau, EYL; Yeung, WSB; Lau, ETK; Tang, MHY; Ho, PC

Pre-implantation genetic diagnosis in Hong Kong. Ng, EHY; Lau, EYL; Yeung, WSB; Lau, ETK; Tang, MHY; Ho, PC Title Pre-implantation genetic diagnosis in Hong Kong Author(s) Ng, EHY; Lau, EYL; Yeung, WSB; Lau, ETK; Tang, MHY; Ho, PC Citation Hong Kong Medical Journal, 2003, v. 9 n. 1, p. 43-47 Issued Date 2003

More information

Comprehensive molecular cytogenetic analysis of the human blastocyst stage

Comprehensive molecular cytogenetic analysis of the human blastocyst stage Human Reproduction Vol.23, No.11 pp. 2596 2608, 2008 Advance Access publication on July 29, 2008 doi:10.1093/humrep/den287 Comprehensive molecular cytogenetic analysis of the human blastocyst stage E.

More information

Copyright 1995 American Society for Reproductive Medicine

Copyright 1995 American Society for Reproductive Medicine FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid free paper in U. S. A. Prospective, auto-controlled study on reinsemination

More information

Polar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute

Polar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives

More information

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and

More information

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions

More information

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Preimplantation Genetic Diagnosis (PGD) in Western Australia Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome

More information

Male factors determining the outcome of intracytoplasmic sperm injection with epididymal and testicular spermatozoa

Male factors determining the outcome of intracytoplasmic sperm injection with epididymal and testicular spermatozoa andrologia 35, 220 226 (2003) Accepted: April 25, 2003 Male factors determining the outcome of intracytoplasmic sperm injection with epididymal and testicular spermatozoa J. U. Schwarzer, K. Fiedler, I.

More information

Concurrent use of flow cytometry and fluorescence in-situ hybridization techniques for detecting faulty meiosis in a human sperm sample

Concurrent use of flow cytometry and fluorescence in-situ hybridization techniques for detecting faulty meiosis in a human sperm sample Molecular Human Reproduction vol.4 no.1 pp. 61 66, 1998 Concurrent use of flow cytometry and fluorescence in-situ hybridization techniques for detecting faulty meiosis in a human sperm sample R.Weissenberg

More information

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

More information

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating

More information

Article Impact of meiotic and mitotic non-disjunction on generation of human embryonic stem cell lines

Article Impact of meiotic and mitotic non-disjunction on generation of human embryonic stem cell lines RBMOn - Vol 18. No 1. 2009 120-126 Reproductive BioMedicine On; www.rbmon.com/article/3656 on web 21 November 2008 Article Impact of meiotic and mitotic non-disjunction on generation of human embryonic

More information

Medical Genetics. Nondisjunction Definition and Examples. Basic Structure of Chromosomes. See online here

Medical Genetics. Nondisjunction Definition and Examples. Basic Structure of Chromosomes. See online here Medical Genetics Nondisjunction Definition and Examples See online here Nondisjunction connotes failure of separation of homologous chromosomes during cell division. It has significant repercussions and

More information

An Update on PGD: Where we are today

An Update on PGD: Where we are today An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future

More information

Blastomere transplantation in human embryos may be a treatment for single gene diseases

Blastomere transplantation in human embryos may be a treatment for single gene diseases FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastomere transplantation in

More information

IVF Patient Information

IVF Patient Information What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a

More information

Luca Gianaroli, M.D.,* M. Cristina Magli, M.Sc.,* Anna P. Ferraretti, Ph.D.,* and Santiago Munné, Ph.D.

Luca Gianaroli, M.D.,* M. Cristina Magli, M.Sc.,* Anna P. Ferraretti, Ph.D.,* and Santiago Munné, Ph.D. FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Preimplantation diagnosis

More information

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic

More information

Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection

Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection Matthew R. Cooperberg, M.D., a Thomas Chi, B.A., a Amir Jad, M.D., a Imok

More information

Cri du chat syndrome after preimplantation genetic diagnosis for reciprocal translocation

Cri du chat syndrome after preimplantation genetic diagnosis for reciprocal translocation CASE REPORT Cri du chat syndrome after preimplantation genetic diagnosis for reciprocal translocation Yinghui Ye, M.D., Ph.D., Yuqin Luo, B.Sc., Yuli Qian, B.Sc., Chenming Xu, Ph.D., and Fan Jin, M.D.

More information

Hold On To Your Dreams

Hold On To Your Dreams Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create

More information

INTRACYTOPLASMIC SPERM INJECTION

INTRACYTOPLASMIC SPERM INJECTION 1 Background... 2 2 Male Factor Infertility... 2 3 ICSI... 3 4 Surgical sperm aspiration... 4 5 What is the chance of success?... 6 6 What are the risks?... 7 M Rajkhowa, October 2004 Authorised by V Kay

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.

24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015. Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and

More information

Karyotype = a test to identify and evaluate the size, shape, and number of chromosomes in a sample of body cells.

Karyotype = a test to identify and evaluate the size, shape, and number of chromosomes in a sample of body cells. Karyotype = a test to identify and evaluate the size, shape, and number of chromosomes in a sample of body cells. Homologous chromosomes are arranged by size, banding patterns, and centromere placement.

More information

No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen thawed epididymal spermatozoa

No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen thawed epididymal spermatozoa Human Reproduction vol.14 no.1 pp.90 95, 1999 No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen thawed epididymal spermatozoa Herman Tournaye 1,4, Talal Merdad

More information

A Stepwise Approach to Embryo Selection and Implantation Success

A Stepwise Approach to Embryo Selection and Implantation Success Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.

More information

Effects of Cryopreservation on the Ultrastructure of Human Testicular Sperm

Effects of Cryopreservation on the Ultrastructure of Human Testicular Sperm Journal of Reproduction & Contraception (2005) 16 (4):195-200 ORIGINAL PAPER Effects of Cryopreservation on the Ultrastructure of Human Testicular Sperm Xin-qiang LAI 1, Wei-jie ZHU 2, Jing LI 3, Fu-xing

More information

Adoption and Foster Care

Adoption and Foster Care GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.

More information

The form of cell division by which gametes, with half the number of chromosomes, are produced. Chromosomes

The form of cell division by which gametes, with half the number of chromosomes, are produced. Chromosomes & Karyotypes The form of cell division by which gametes, with half the number of chromosomes, are produced. Homologous Chromosomes Pair of chromosomes (maternal and paternal) that are similar in shape,

More information

Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples

Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples Human Reproduction, Vol.24, No.11 pp. 2951 2959, 2009 Advanced Access publication on August 3, 2009 doi:10.1093/humrep/dep272 ORIGINAL ARTICLE Reproductive genetics Cumulative reproductive outcome after

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

Current value of preimplantation genetic aneuploidy screening in IVF

Current value of preimplantation genetic aneuploidy screening in IVF Human Reproduction Update, Vol.13, No.1 pp. 15 25, 2007 Advance Access publication September 7, 2006 doi:10.1093/humupd/dml043 Current value of preimplantation genetic aneuploidy screening in IVF P.Donoso

More information

Assisted Reproductive Technology National Summary Report Belgium 2015

Assisted Reproductive Technology National Summary Report Belgium 2015 Assisted Reproductive Technology National Summary Report Belgium 2015 College van Geneesheren Reproductieve Geneeskunde Collège de Médecins Médecine de la Reproduction College of Physicians Reproductive

More information

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Human Reproduction Vol.19, No.11 pp. 2550 2554, 2004 Advance Access publication August 6, 2004 doi:10.1093/humrep/deh447 Should we advise patients undergoing IVF to start a cycle leading to a day 3 or

More information

Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols*t

Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols*t FERTILITY AND STERILITY Vol. 63, No. I, January 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prospective randomized study on the cryopreservation

More information

Effect of chromosomal translocations on the development of preimplantation human embryos in vitro

Effect of chromosomal translocations on the development of preimplantation human embryos in vitro FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A.,2 Effect of chromosomal

More information

Ch 20: Reproduction. Keypoints: Human Chromosomes Gametogenesis Fertilization Early development Parturition

Ch 20: Reproduction. Keypoints: Human Chromosomes Gametogenesis Fertilization Early development Parturition Ch 20: Reproduction Keypoints: Human Chromosomes Gametogenesis Fertilization Early development Parturition SLOs Contrast mitosis/meiosis, haploid/diploid, autosomes/sex chromosomes. Outline the hormonal

More information

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2015 1 1. Introduction This policy sets out the entitlement and service that will

More information

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2 Welcome Your fertility treatment journey begins here Fertility treatment can be complicated Managing expectations, keeping track of medications and appointments, remembering all the information your physician

More information

bioscience explained Vol 4 No 1 Kersti Lundin Unit of Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden

bioscience explained Vol 4 No 1 Kersti Lundin Unit of Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden Kersti Lundin Unit of Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden In vitro fertilisation where are we now? History (b) (a) Fig 1. (a) At oocyte pick-up, the oocytes are aspirated

More information

Article Paternal gonadal mosaicism detected in a couple with recurrent abortions undergoing PGD: FISH analysis of sperm nuclei proves valuable

Article Paternal gonadal mosaicism detected in a couple with recurrent abortions undergoing PGD: FISH analysis of sperm nuclei proves valuable RBMOnline - Vol 9. No 2. 2004 225-230 Reproductive BioMedicine Online; www.rbmonline.com/article/1346 on web 18 June 2004 Article Paternal gonadal mosaicism detected in a couple with recurrent abortions

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

Zygotes showing a single pronucleus

Zygotes showing a single pronucleus In vitro development and chromosome constitution of embryos derived from monopronucleated zygotes after intracytoplasmic sperm injection Sílvia Mateo, M.Sc., a Monica Parriego, M.Sc., a Montserrat Boada,

More information

Outcome of repeated micro-surgical testicular sperm extraction in patients with non-obstructive azoospermia

Outcome of repeated micro-surgical testicular sperm extraction in patients with non-obstructive azoospermia Repeated micro-surgical testicular sperm extraction DOI: 10.1111/j.1745-7262.2007.00273.x www.asiaandro.com. Original Article. Outcome of repeated micro-surgical testicular sperm extraction in patients

More information

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization IVF 1878 - first reported attempts at IVF 1959 - IVF births in rabbits in USA 1968

More information

Article Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients

Article Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients RBMOnline - Vol 10. No 6. 2005 735 739 Reproductive BioMedicine Online; www.rbmonline.com/article/1678 on web 13 April 2005 Article Influence of spermatogenic profile and meiotic abnormalities on reproductive

More information

Abstract. Introduction. RBMOnline - Vol 11. No Reproductive BioMedicine Online; on web 11 August 2005

Abstract. Introduction. RBMOnline - Vol 11. No Reproductive BioMedicine Online;  on web 11 August 2005 RBMOnline - Vol 11. No 4. 2005 497 506 Reproductive BioMedicine Online; www.rbmonline.com/article/1712 on web 11 August 2005 Article FISH screening of aneuploidies in preimplantation embryos to improve

More information

MALE FACTOR. Baylor College of Medicine, Houston, Texas

MALE FACTOR. Baylor College of Medicine, Houston, Texas FERTILITY AND STERILITY VOL. 76, NO. 5, NOVEMBER 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. MALE FACTOR Increased

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Deliveries of normal healthy babies from embryos originating from oocytes showing the presence of smooth endoplasmic reticulum aggregates

Deliveries of normal healthy babies from embryos originating from oocytes showing the presence of smooth endoplasmic reticulum aggregates Human Reproduction, Vol.28, No.8 pp. 2111 2117, 2013 Advanced Access publication on May 21, 2013 doi:10.1093/humrep/det241 ORIGINAL ARTICLE Embryology Deliveries of normal healthy babies from embryos originating

More information

PATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh

PATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh PREIMPLANTATION GENETIC SCREENING FOR ANEUPLOIDY SCREENING INTRODUCTION Preimplantation genetic screening (PGS) is used in conjunction with in-vitro fertilization (IVF) to screen embryos for numerical

More information